Physician profile
Vy Jocson
NPI 1124551585
$63,712.06
in general payments reported to CMS, 2019-2025
13 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.06 · 2020: $153 · 2021: $523 · 2022: $3,369 · 2023: $16K · 2024: $29K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Travel and Lodging: $22K · Food and Beverage: $6,209 · Education: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,250.00 |
| Travel and Lodging | $22,243.56 |
| Food and Beverage | $6,208.61 |
| Education | $929.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21,833.19 | 2023-2025 | Ensite, Ensite Precision, Gallant |
| Medtronic, INC. | $18,992.82 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Evera Mri Xt Dr Surescan |
| Biotronik INC. | $9,252.09 | 2022-2025 | Pamira, Solia, Selectra |
| Boston Scientific Corporation | $4,892.27 | 2020-2025 | General - Ep, Ingevity+, General - Therapies |
| Medical Device Business Services, INC. | $4,546.65 | 2024 | Carto 3 |
| Biosense Webster, INC. | $2,739.68 | 2024-2025 | Carto 3 |
| Philips North America LLC | $737.66 | 2023 | (9520) Igt Devices Undivided, (9520) Igt Devices Und |
| Cardiva Medical, INC. | $233.61 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm, Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.96 | 2021-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $146.75 | 2019-2021 | |
| Amgen INC. | $54.40 | 2021 | |
| Pfizer INC. | $35.00 | 2019-2021 | |
| Cordis US Corp. | $19.98 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vy Jocson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.